A Peptidomimetic Targeting White Fat Causes Weight Loss and Improved Insulin Resistance in Obese Monkeys
- 9 November 2011
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 3 (108), 108ra112
- https://doi.org/10.1126/scitranslmed.3002621
Abstract
A peptide-based drug that targets the vasculature of adipose tissue induces weight loss and improves metabolic function in spontaneously obese monkeys.Keywords
This publication has 43 references indexed in Scilit:
- Vascular ligand-receptor mapping by direct combinatorial selection in cancer patientsProceedings of the National Academy of Sciences of the United States of America, 2011
- Current and Future Drug Targets in Weight ManagementPharmaceutical Research, 2010
- Peptide Designed to Elicit Apoptosis in Adipose Tissue Endothelium Reduces Food Intake and Body WeightDiabetes, 2010
- Predictive models of insulin resistance derived from simple morphometric and biochemical indices related to obesity and the metabolic syndrome in baboonsCardiovascular Diabetology, 2009
- Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studiesThe Lancet, 2009
- An unrecognized extracellular function for an intracellular adapter protein released from the cytoplasm into the tumor microenvironmentProceedings of the National Academy of Sciences of the United States of America, 2009
- White Fat Progenitor Cells Reside in the Adipose VasculatureScience, 2008
- Targeted Induction of Lung Endothelial Cell Apoptosis Causes Emphysema-like Changes in the MousePublished by Elsevier BV ,2008
- Treatment of hypoxia‐induced retinopathy with targeted proapoptotic peptidomimetic in a mouse model of diseaseThe FASEB Journal, 2007
- Reciprocal variations in insulin-stimulated glucose uptake and pancreatic insulin secretion in women with normal glucose toleranceJournal of the Society for Gynecologic Investigation, 1995